0000882104-18-000104.txt : 20180927 0000882104-18-000104.hdr.sgml : 20180927 20180927164124 ACCESSION NUMBER: 0000882104-18-000104 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180925 FILED AS OF DATE: 20180927 DATE AS OF CHANGE: 20180927 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Stone Christopher Lewis CENTRAL INDEX KEY: 0001453373 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19756 FILM NUMBER: 181091428 MAIL ADDRESS: STREET 1: 932 SOUTHWOOD BLVD. CITY: INCLINE VILLAGE STATE: NV ZIP: 89451 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PDL BIOPHARMA, INC. CENTRAL INDEX KEY: 0000882104 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 943023969 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 932 SOUTHWOOD BLVD CITY: INCLINE VILLAGE STATE: NV ZIP: 89451 BUSINESS PHONE: 775-832-8500 MAIL ADDRESS: STREET 1: 932 SOUTHWOOD BLVD CITY: INCLINE VILLAGE STATE: NV ZIP: 89451 FORMER COMPANY: FORMER CONFORMED NAME: PROTEIN DESIGN LABS INC/DE DATE OF NAME CHANGE: 19930328 4 1 wf-form4_153808086599965.xml FORM 4 X0306 4 2018-09-25 0 0000882104 PDL BIOPHARMA, INC. PDLI 0001453373 Stone Christopher Lewis C/O PDL BIOPHARMA, INC. 932 SOUTHWOOD BLVD. INCLINE VILLAGE NV 89451 0 1 0 0 VP, Gen. Counsel & Secretary Stock Option (right to buy) 2.52 2018-09-25 4 A 0 339623 0 A 2028-09-25 Common stock 339623.0 339623 D The stock options will vest on a monthly basis pro rata over the 48 months following January 1, 2018, provided that the recipient's continuous service has not terminated prior to the applicable vesting date, subject to earlier vesting upon a change in control and certain qualifying terminations of employment provided in the severance agreement between the issuer and the recipient. /s/ Christopher Stone 2018-09-26